Marsha Grattan

1.0k total citations
12 papers, 871 citations indexed

About

Marsha Grattan is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Marsha Grattan has authored 12 papers receiving a total of 871 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 4 papers in Oncology and 3 papers in Genetics. Recurrent topics in Marsha Grattan's work include Cell death mechanisms and regulation (3 papers), Diabetes and associated disorders (3 papers) and Angiogenesis and VEGF in Cancer (2 papers). Marsha Grattan is often cited by papers focused on Cell death mechanisms and regulation (3 papers), Diabetes and associated disorders (3 papers) and Angiogenesis and VEGF in Cancer (2 papers). Marsha Grattan collaborates with scholars based in Canada, United States and Switzerland. Marsha Grattan's co-authors include Terry L. Delovitch, Eric E. Schmidt, Craig Meagher, Ann F. Chambers, A. C. Groom, Ian C. MacDonald, Rama Khokha, V L Morris, Qing‐Sheng Mi and Vincent L. Morris and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Experimental Medicine.

In The Last Decade

Marsha Grattan

12 papers receiving 848 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Marsha Grattan Canada	11	378	312	255	207	185	12	871
J C Pena United States	9	511 1.4×	254 0.8×	455 1.8×	83 0.4×	210 1.1×	9	1.0k
Jiří Kalabis United States	12	625 1.7×	421 1.3×	152 0.6×	65 0.3×	192 1.0×	17	1.1k
Annette L. Rothermel United States	10	841 2.2×	374 1.2×	481 1.9×	115 0.6×	98 0.5×	16	1.3k
D. Mohanraj United States	15	541 1.4×	181 0.6×	168 0.7×	61 0.3×	211 1.1×	43	987
Alan R. Brooks United States	10	594 1.6×	177 0.6×	162 0.6×	241 1.2×	59 0.3×	19	975
Arsen Zakarian Canada	14	432 1.1×	284 0.9×	756 3.0×	180 0.9×	62 0.3×	17	1.2k
G W Krissansen New Zealand	16	473 1.3×	202 0.6×	403 1.6×	84 0.4×	192 1.0×	28	1.1k
Bellinda A. Bladergroen Netherlands	17	399 1.1×	200 0.6×	471 1.8×	68 0.3×	156 0.8×	19	1.0k
Quansheng Song China	20	667 1.8×	469 1.5×	301 1.2×	79 0.4×	168 0.9×	37	1.2k
Cuifen Huang China	14	735 1.9×	152 0.5×	67 0.3×	134 0.6×	183 1.0×	61	1.1k

Countries citing papers authored by Marsha Grattan

Since Specialization

Citations

This map shows the geographic impact of Marsha Grattan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marsha Grattan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marsha Grattan more than expected).

Fields of papers citing papers by Marsha Grattan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marsha Grattan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marsha Grattan. The network helps show where Marsha Grattan may publish in the future.

Co-authorship network of co-authors of Marsha Grattan

This figure shows the co-authorship network connecting the top 25 collaborators of Marsha Grattan. A scholar is included among the top collaborators of Marsha Grattan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marsha Grattan. Marsha Grattan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Chen, Wei, Konstantin V. Salojin, Qing‐Sheng Mi, et al.. (2003). Insulin-Like Growth Factor (IGF)-I/IGF-Binding Protein-3 Complex: Therapeutic Efficacy and Mechanism of Protection against Type 1 Diabetes. Endocrinology. 145(2). 627–638. 57 indexed citations

Mi, Qing‐Sheng, Dalam Ly, Salah-Eddine Lamhamedi-Cherradi, et al.. (2003). Blockade of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Exacerbates Type 1 Diabetes in NOD Mice. Diabetes. 52(8). 1967–1975. 88 indexed citations

Grattan, Marsha, Qing‐Sheng Mi, Craig Meagher, & Terry L. Delovitch. (2002). Congenic Mapping of the Diabetogenic LocusIdd4to a 5.2-cM Region of Chromosome 11 in NOD Mice. Diabetes. 51(1). 215–223. 58 indexed citations

Zhang, Jian, Jianxin Gao, Qing Shao, et al.. (2000). Regulation of FAS Ligand Expression during Activation-Induced Cell Death in T Cells by p38 Mitogen-Activated Protein Kinase and C-Jun Nh2-Terminal Kinase. The Journal of Experimental Medicine. 191(6). 1017–1030. 80 indexed citations

Cameron, Mark J., Guillermo Arreaza, Marsha Grattan, et al.. (2000). Differential Expression of CC Chemokines and the CCR5 Receptor in the Pancreas Is Associated with Progression to Type I Diabetes. The Journal of Immunology. 165(2). 1102–1110. 126 indexed citations

Schmidt, Eric E., Ian C. MacDonald, V L Morris, et al.. (1996). Independence of metastatic ability and extravasation: metastatic ras-transformed and control fibroblasts extravasate equally well.. Proceedings of the National Academy of Sciences. 93(20). 11080–11084. 91 indexed citations

Morris, Vincent L., Eric E. Schmidt, Ian C. MacDonald, et al.. (1995). Effects of the Disintegrin Eristostatin on Individual Steps of Hematogenous Metastasis. Experimental Cell Research. 219(2). 571–578. 55 indexed citations

Morris, V L, et al.. (1995). Isolation and sequence analysis of the Pseudomonas syringae pv. tomato gene encoding a 2,3-diphosphoglycerate-independent phosphoglyceromutase. Journal of Bacteriology. 177(7). 1727–1733. 22 indexed citations

MacDonald, Ian C., Eric E. Schmidt, V L Morris, et al.. (1995). Fate of melanoma cells entering the microcirculation: over 80% survive and extravasate.. PubMed. 55(12). 2520–3. 148 indexed citations

10.

Morris, Vincent L., Ian C. MacDonald, Eric E. Schmidt, et al.. (1994). Mammary carcinoma cell lines of high and low metastatic potential differ not in extravasation but in subsequent migration and growth. Clinical & Experimental Metastasis. 12(6). 357–367. 115 indexed citations

11.

Altus, Michael S., et al.. (1988). hsp70 mRNA accumulates in LLC-PK1 pig kidney cells treated with calcitonin but not with 8-bromo-cyclic AMP.. Journal of Biological Chemistry. 263(13). 6183–6187. 21 indexed citations

12.

Nagamine, Yoshikuni, David Pearson, & Marsha Grattan. (1985). Exon-intron boundary sliding in the generation of two mRNAs coding for porcine urokinase-like plasminogen activator. Biochemical and Biophysical Research Communications. 132(2). 563–569. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact